Evidence map›Paper›PMID 35573058›Full record

ArticleEpilepsy & behavior reports2022

Early epilepsy surgery for non drug-resistant patients.

Veronica Pelliccia, Francesco Deleo, Francesca Gozzo, Ginevra Giovannelli, Roberto Mai, Massimo Cossu, Laura Tassi

Abstract read
In one paragraph

Article in Epilepsy & behavior reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Head to head comparison between arterial spin labelling MRI and [Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Observational
  6. Seminars in epileptology: Presurgical epilepsy evaluation.Epileptic disorders : international epilepsy journal with videotape · 2025
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Veronica Pelliccia"Claudio Munari" Epilepsy Surgery Center, Niguarda Hospital, Piazza Ospedale Maggiore 3, 20162 Milano, Italy.
Francesco DeleoClinical Epileptology and Experimental Neurophysiology Unit, Fondazione IRCCS, Istituto Neurologico "C. Besta", Via Celoria 11, 20133 Milano, Italy.
Francesca Gozzo"Claudio Munari" Epilepsy Surgery Center, Niguarda Hospital, Piazza Ospedale Maggiore 3, 20162 Milano, Italy.
Ginevra Giovannelli"Claudio Munari" Epilepsy Surgery Center, Niguarda Hospital, Piazza Ospedale Maggiore 3, 20162 Milano, Italy.
Roberto Mai"Claudio Munari" Epilepsy Surgery Center, Niguarda Hospital, Piazza Ospedale Maggiore 3, 20162 Milano, Italy.
Massimo Cossu"Claudio Munari" Epilepsy Surgery Center, Niguarda Hospital, Piazza Ospedale Maggiore 3, 20162 Milano, Italy.
Laura Tassi"Claudio Munari" Epilepsy Surgery Center, Niguarda Hospital, Piazza Ospedale Maggiore 3, 20162 Milano, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of epilepsy treatment is to achieve seizure freedom. Surgery is often still considered a late option when pharmacological treatments have failed and epilepsy has become drug-resistant. We analyse the clinical features and surgical outcome in patients who underwent surgery without experiencing drug-resistance comparing with those observed in patients who became drug-resistant. Two-hundred and fifty patients with symptomatic focal epilepsy (12.1% of patients who underwent surgery at the "Claudio Munari" Epilepsy Surgery Center) were selected on the basis of initial period of seizure freedom and followed-up for at least 12 months. Patients were divided into two groups: those who underwent surgery during the initial period of seizure freedom (n = 74), and those who underwent surgery after an initial seizure-free period followed by drug-resistance (n = 176). Outcomes were significantly better in non-drug-resistant patients (p < 0.001), all of whom had Engel class Ia or Ic. In the drug-resistant group, 136 patients (77.3%) had class Ia or Ic. The median post-operative follow-up was respectively 75.0 and 84.0 months. Epilepsy surgery is a successful treatment, especially for non-drug-resistant patients with focal epilepsy with structural etiology. The timing of surgery affects the outcomes, and "early" surgery should be preferred to prevent likely drug-resistance and to improve prognosis.

Indexed as

Anti-seizure medicationsChildhood epilepsyEpilepsy surgeryNon-drug-resistant epilepsySymptomatic epilepsy

Identifiers

PMID35573058
PMCPMC9096667

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.